Riskpilot← Back to searchSign inGet full accessDatec Medico Invest ApS
APSActiveCVR 43282743Ved Skoven 35Activities of holding companies · NACE 6421Est. 2022— employees
Revenue 2024
DKK -14K
+10% vs 2023
EBITDA margin
100.0%
-10% vs 2023
Equity ratio
-102.6%
Financial strength
Net profit 2024
DKK -4,5M
-26% vs 2023
| Revenue | DKK -14K | +10% |
| EBITDA | DKK -14K | -10% |
| Net profit | DKK -4,5M | -26% |
| Total assets | DKK 5,7M | -42% |
| Equity | DKK -5,9M | -330% |
| Employees | — | — |
Legal name
Datec Medico Invest ApS
CVR number
43282743
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
24. maj 2022
Share capital
DKK 1.900.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør sammen med bestyrelsesformanden eller af den samlede
bestyrelse i forening.
Company purpose
Selskabets formål er at besidde kapitalandele i andre selskaber samt enhver anden aktivitet, der efter direktionens skøn står i forbindelse hermed.
Address
Ved Skoven 35
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | -8 | -13 | -14 |
| Staff expenses | -0 | -0 | -0 |
| EBITDA | -8 | -13 | -14 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -8 | -13 | -14 |
| Net financials | -1.712 | -3.550 | -4.608 |
| Profit before tax | -1.720 | -3.564 | -4.622 |
| Tax | -0 | -0 | -120 |
| Net profit | -1.720 | -3.564 | -4.503 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 9.707 | 9.874 | 5.721 |
| Equity | 2.200 | -1.364 | -5.869 |
| Long-term debt | 5.900 | 4.600 | 3.900 |
| Short-term debt | 1.607 | 6.638 | 7.690 |
| Total debt | 7.507 | 11.238 | 11.590 |
EBITDA margin
-1437400.0%
This company
15.8%
Market median
-9097568% vs market
20222024
Equity ratio
-102.6%
This company
38.2%
Market median
-369% vs market
20222024
Return on equity
-450252300.0%
This company
18.4%
Market median
-2447023470% vs market
20222024
Net profit margin
-450252300.0%
This company
8.1%
Market median
-5558670470% vs market
20222024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
1.97×
This company
0.62×
Market median
-218% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ES Management | Management | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2022 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2025 | |
| Company | 10–14.99% | 10–14.99% | 2023 | |
| Company | 20–24.99% | 20–24.99% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TELLUS HOLDING ApS
Datec Medico Invest ApS Board members of Datec Medico Invest ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Sejersen | Management | 0 companies |
| Lars Laustsen Gleerup | Chairman | 0 companies |
| Rasmus Bak Skjødt | Board of Directors | 0 companies |
| Jesper Møller Vejlin | Board of Directors | 0 companies |